![Christopher Tapper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Tapper
Direktör/Styrelseledamot på
Microbiotica Ltd.
Profil
Christopher Tapper currently works at Microbiotica Ltd., as Director from 2020, Exvastat Ltd., as Director from 2020, and Cambridge Innovation Capital Ltd, as Principal.
Mr. Tapper received his undergraduate degree in 2014 from the University of Cambridge.
Aktiva positioner av Christopher Tapper
| Företag | Position | Start |
|---|---|---|
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Privat kapitalinvesterare | - |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Direktör/Styrelseledamot | 2020-08-01 |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Direktör/Styrelseledamot | 2020-09-01 |
Christopher Tappers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
40
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Finance |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Health Technology |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Health Technology |
